期刊文献+

Nemo样激酶与肿瘤相关性疾病研究进展 被引量:2

Research progress of nemo-like kinase( NLK)and cancer-related diseases
下载PDF
导出
摘要 Nemo样激酶(Nemo-like kinase,NLK)是在进化上高度保守的MAPK样激酶,广泛分布于机体各组织器官。诸多研究发现,NLK可通过调控多种信号通路分子如Wnt/β-catenin,c-Myb,caspase-3参与了肿瘤细胞生长、分化,增殖和凋亡等过程。异常表达的NLK在肿瘤性疾病的发生发展以及在判断疾病的预后等方面都扮演重要的角色。该文就NLK调控肿瘤性疾病发生发展的功能和机制研究进行综合论述。 Nemo-like kinase(NLK)is an evolutionarily conserved MAPK-related kinase that is broadly expressed in mammalian organ systems.Accumulating evidence indicates that NLK is involved in cancer cell growth,differentiation,proliferation and apoptosis via the regulation of multiple signal molecules,including Wnt/β-catenin,c-Myb and caspase-3.Aberrant expression of NLK plays a pivotal role in the progression and development of cancer and in prognosis evaluation of cancer.In this review,we will make a summary on the func-tion and underlying mechanism of NLK in modulating the process of various cancers.
作者 米志静
出处 《安徽医药》 CAS 2016年第11期2024-2027,共4页 Anhui Medical and Pharmaceutical Journal
关键词 NEMO 样激酶 WNT/Β-CATENIN 肿瘤 Nemo-like kinase Wnt/β-catenin Cancer
  • 相关文献

参考文献1

二级参考文献32

  • 1Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID:21296855 DOI: 10.3322/caac.20107].
  • 2Ou J, Peng Y, Deng J, Miao H, Zhou J, Zha L, Zhou R, Yu L, ShiH, Liang H. Endothelial cell-derived fibronectin extra domainA promotes colorectal cancer metastasis via inducing epithelialmesenchymaltransition. Carcinogenesis 2014; 35: 1661-1670[PMID: 24743511 DOI: 10.1093/carcin/bgu090].
  • 3Lonnroth C, Andersson M, Asting AG, Nordgren S, Lundholm K.Preoperative low dose NSAID treatment influences the genes forstemness, growth, invasion and metastasis in colorectal cancer. IntJ Oncol 2014; 45: 2208-2220 [PMID: 25340937 DOI: 10.3892/ijo.2014.2686].
  • 4Gao XH, Yu ZQ, Zhang C, Bai CG, Zheng JM, Fu CG. DNAtopoisomerase II alpha: a favorable prognostic factor in colorectalcaner. Int J Colorectal Dis 2012; 27: 429-435 [PMID: 22076611DOI: 10.1007/s00384-011-1346-x].
  • 5Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P,Schlitt HJ. Oxaliplatin-based versus irinotecan-based hyperthermicintraperitoneal chemotherapy (HIPEC) in patients with peritonealmetastasis from appendiceal and colorectal cancer: a retrospectiveanalysis. BMC Cancer 2014; 14: 807 [PMID: 25369730 DOI: 10.1186/1471-2407-14-807].
  • 6Nakanishi M, Kuriu Y, Murayama Y, Konishi H, Komatsu S,Shiozaki A, Ikoma H, Kubota T, Ichikawa D, Fujiwara H, OkamotoK, Sakakura C, Otsuji E. Efficacy of perioperative chemotherapyin patients with colorectal cancer undergoing hepatectomy forresectable synchronous liver metastasis. Hepatogastroenterology2014; 61: 1582-1587 [PMID: 25436346].
  • 7Ji K, Ye L, Ruge F, Hargest R, Mason MD, Jiang WG. Implicationof metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R incolorectal cancer. BMC Cancer 2014; 14: 723 [PMID: 25260785DOI: 10.1186/1471-2407-14-723].
  • 8Ahmed IA, Kelly SB, Anderson JJ, Angus B, Challen C, Lunec J.The predictive value of p53 and p33(ING1b) in patients with Dukes C colorectal cancer. Colorectal Dis 2008; 10: 344-351 [PMID:17949449 DOI: 10.1111/j.1463-1318.2007.01317.x].
  • 9Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Miyata H,Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, NozawaH, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J,Hashiguchi Y, Sugihara K, Watanabe T. Prognostic impact of primarytumor resection and lymph node dissection in stage IV colorectalcancer with unresectable metastasis: a propensity score analysisin a multicenter retrospective study. Ann Surg Oncol 2014; 21:2949-2955 [PMID: 24763981 DOI: 10.1245/s10434-014-3719-1].
  • 10Lou X, Kang B, Zhang J, Hao C, Tian X, Li W, Xu N, Lu Y, Liu S.MFAP3L activation promotes colorectal cancer cell invasion andmetastasis. Biochim Biophys Acta 2014; 1842: 1423-1432 [PMID:24735981 DOI: 10.1016/j.bbadis.2014.04.006].

共引文献4

同被引文献5

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部